Topterone (, ) (developmental code name WIN-17665), also known as 17α-propyltestosterone (or simply propyltestosterone) or as 17α-propylandrost-4-en-17β-ol-3-one, is a
steroidal antiandrogen
A steroidal antiandrogen (SAA) is an antiandrogen with a steroidal chemical structure. They are typically antagonists of the androgen receptor (AR) and act both by blocking the effects of androgens like testosterone and dihydrotestosterone (DHT) ...
that was first reported in 1978 and was developed for
topical administration
A topical medication is a medication that is applied to a particular place on or in the body. Most often topical medication means application to body surfaces such as the skin or mucous membranes to treat ailments via a large range of classes ...
but, due to poor effectiveness, was never marketed.
See also
*
Steroidal antiandrogen
A steroidal antiandrogen (SAA) is an antiandrogen with a steroidal chemical structure. They are typically antagonists of the androgen receptor (AR) and act both by blocking the effects of androgens like testosterone and dihydrotestosterone (DHT) ...
*
List of steroidal antiandrogens
This is a list of steroidal antiandrogens.
Progesterone derivatives
* 11α-Hydroxyprogesterone = 11α-hydroxyprogesterone
* Chlormadinone acetate = 17α-acetoxy-6-chloro-δ6-progesterone
* Clometerone (L-38000) = 6α-chloro-16α-methylproge ...
References
Abandoned drugs
Androstanes
Anti-acne preparations
Steroidal antiandrogens
{{Dermatologic-drug-stub